Developer docs
API playgroundTry for free, no card

Search company profiles

DataPathology

Full company profile

uuid0003wbb

Namestring
DataPathology
Company typeenum
Private
Founded yearint
2020
Descriptiontext

DataPathology is a Casablanca-based MedTech startup founded in 2020 that operates a digital pathology platform enabling remote pathological diagnosis, primarily focused on cancer diagnosis for hospitals, clinics, and diagnostic laboratories across Morocco and Africa. The platform addresses acute shortages of trained pathologists in underserved African markets and rising cancer caseloads by digitizing slide workflows and connecting requesting institutions with remote diagnostic capacity, with stated reach spanning 14+ countries across Africa and Europe.

The company's core product offering centers on a digital pathology platform that delivers rapid and secure remote pathological diagnosis, with features described as "Remote Pathological Diagnosis" and "Digital Cancer Diagnosis Systems." Technical differentiation is framed around domain specialization in pathology and accuracy/precision in cancer diagnosis, though the input contains no disclosure of proprietary AI models, patented components, or third-party model dependencies; the platform appears to function primarily as a digital workflow and connectivity layer rather than as an AI-native diagnostic engine.

DataPathology monetizes through subscription and recurring service revenue from institutional customers under an enterprise field sales motion that targets hospitals, clinics, and diagnostic laboratories directly. The company has raised approximately $1.2 million in disclosed funding across two rounds (a ~$223K seed led by Witamax in September 2021 and a ~$982K round led by Azur Innovation Fund in May 2023), and reports a team size of 1-10 employees. Co-founders Hicham El Attar and Mohammed El Khannoussi lead the company, which operates as an independent private entity with no disclosed parent company or public listing.

Short descriptiontext

DataPathology is a Casablanca-based MedTech startup operating a digital pathology platform that delivers remote pathological diagnosis, primarily for cancer, to hospitals, clinics, and diagnostic laboratories across Morocco and Africa.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCasablanca, Morocco
HQ citystring
Casablanca
HQ countrystring
Morocco
HQ regionstring
Africa
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital pathology services, remote cancer diagnostics, telepathology platform, pathology consultation services, medtech diagnostics software
Industry2 codes
PRIMARYHLACAMAJ
Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLALAGAH
Oncology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code1 code
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Digital Pathology / Tele-pathology Diagnostics
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Digital Pathology Diagnostic Services
TypeSubscription Recurring
Description

Provides digital solutions for rapid and secure pathological diagnosis to hospitals, clinics, and diagnostic laboratories across Morocco and Africa

challenge.ma
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

DataPathology provides a digital pathology platform that enables remote pathological diagnosis, offering rapid and secure digital solutions for cancer diagnosis. The platform serves hospitals, clinics, and diagnostic laboratories across Morocco and Africa, addressing the critical shortage of pathologists and rising cancer cases in underserved regions. The company operates a network of connected diagnostic centers to expand access to specialized pathology expertise.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Increased network coverage for pathological diagnosis across Morocco and Africa
Product overview1 text field

DataPathology offers a digital pathology platform that enables remote pathological diagnosis, providing digital solutions for rapid and secure cancer diagnosis. The company operates as a single unified product offering focused on connecting diagnostic laboratories and supporting clinical institutions facing challenges such as lack of pathologists and rising cancer cases.

Product and service1 record
1DataPathology Platform
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based AI pathology company providing digital diagnostic solutions for cancer. Directly comparable technology stack (digital pathology + AI-assisted diagnosis) and target end market (hospitals seeking accurate, scalable cancer diagnosis), though operating at much larger scale and capital base.

TypeDirect peer
Description

Digital pathology platform company offering software for pathology workflows and AI-enabled cancer diagnosis. Closely comparable product category (cloud-based pathology platform serving hospitals and labs) with overlapping customer profile of clinical institutions seeking to modernize cancer diagnostics.

TypeDirect peer
Description

Israel-based AI pathology company focused on cancer diagnosis in clinical workflows. Direct overlap on AI-augmented cancer diagnosis for hospital labs; comparable technology positioning around augmenting pathologist capacity.

TypeDirect peer
Description

Digital pathology AI company building clinical-grade diagnostic products for cancer. Directly comparable in the digital cancer diagnosis space with regulatory-cleared products serving similar hospital and reference lab customers.

TypeDirect peer
Description

Provider of digital pathology image analysis software used by research and clinical pathology labs. Comparable as a pathology software platform serving laboratories, with overlapping customer base of diagnostic centers and hospitals.

TypeBroad incumbent
Description

Swedish medical imaging IT company with a digital pathology module that integrates with hospital PACS systems. Comparable as a digital pathology vendor to hospitals, but operates as a broader imaging/IT incumbent rather than a pathology specialist.

TypeBroad incumbent
Description

Multinational health technology major with a digital pathology solution sold to hospitals and labs. Comparable end market and use case (scanner + workflow + remote review), but part of a much broader medtech portfolio rather than a focused pathology offering.

TypeBroad incumbent
Description

Global pathology equipment and workflow vendor (owned by Danaher) covering slide scanners, reagents, and image management. Comparable customer base of pathology labs and hospitals, but competes via capital equipment and consumables rather than a software-first remote-diagnosis model.

TypeEmerging player
Description

AI-for-health company with pathology and oncology applications for hospitals and pharma. Partial overlap on AI-driven cancer diagnosis; broader scope into drug discovery makes it an emerging adjacent player rather than a direct pathology services competitor.

10Hurone AI
TypeRegional player
Description

US-based but Africa-focused oncology AI company building decision-support tools for cancer treatment in low-resource settings. Highly comparable mission (improving cancer care in underserved African contexts) and adjacent technology, making it the closest thematically aligned peer in DataPathology's geographic niche.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DataPathology

Digital Pathology / Tele-pathology Diagnosticsdatapathology.ma

DataPathology is a Casablanca-based MedTech startup operating a digital pathology platform that delivers remote pathological diagnosis, primarily for cancer, to hospitals, clinics, and diagnostic laboratories across Morocco and Africa.

What DataPathology does

DataPathology is a Casablanca-based MedTech startup founded in 2020 that operates a digital pathology platform enabling remote pathological diagnosis, primarily focused on cancer diagnosis for hospitals, clinics, and diagnostic laboratories across Morocco and Africa. The platform addresses acute shortages of trained pathologists in underserved African markets and rising cancer caseloads by digitizing slide workflows and connecting requesting institutions with remote diagnostic capacity, with stated reach spanning 14+ countries across Africa and Europe.

The company's core product offering centers on a digital pathology platform that delivers rapid and secure remote pathological diagnosis, with features described as "Remote Pathological Diagnosis" and "Digital Cancer Diagnosis Systems." Technical differentiation is framed around domain specialization in pathology and accuracy/precision in cancer diagnosis, though the input contains no disclosure of proprietary AI models, patented components, or third-party model dependencies; the platform appears to function primarily as a digital workflow and connectivity layer rather than as an AI-native diagnostic engine.

DataPathology monetizes through subscription and recurring service revenue from institutional customers under an enterprise field sales motion that targets hospitals, clinics, and diagnostic laboratories directly. The company has raised approximately $1.2 million in disclosed funding across two rounds (a ~$223K seed led by Witamax in September 2021 and a ~$982K round led by Azur Innovation Fund in May 2023), and reports a team size of 1-10 employees. Co-founders Hicham El Attar and Mohammed El Khannoussi lead the company, which operates as an independent private entity with no disclosed parent company or public listing.

DataPathology firmographics

Firmographics
Name
DataPathology
Website
https://datapathology.ma
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
DataPathology is a Casablanca-based MedTech startup operating a digital pathology platform that delivers remote pathological diagnosis, primarily for cancer, to hospitals, clinics, and diagnostic laboratories across Morocco and Africa.
Ownership category
akta.pro rank

DataPathology industry classification

Industry
Product category
Digital Pathology / Tele-pathology Diagnostics
NAICS
Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLACAMAJ
Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLALAGAH
Oncology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • Digital pathology services
  • Remote cancer diagnostics
  • Telepathology platform
  • Pathology consultation services
  • Medtech diagnostics software

Where DataPathology is headquartered

Location

Headquarters

HQ city
Casablanca
HQ country
Morocco
HQ region
Africa

Offices1 record

Markets served

DataPathology business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Digital Pathology Diagnostic Services: Provides digital solutions for rapid and secure pathological diagnosis to hospitals, clinics, and diagnostic laboratories across Morocco and Africa

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

DataPathology product offering

Product offering

Core offering

DataPathology provides a digital pathology platform that enables remote pathological diagnosis, offering rapid and secure digital solutions for cancer diagnosis. The platform serves hospitals, clinics, and diagnostic laboratories across Morocco and Africa, addressing the critical shortage of pathologists and rising cancer cases in underserved regions. The company operates a network of connected diagnostic centers to expand access to specialized pathology expertise.

Product overview

DataPathology offers a digital pathology platform that enables remote pathological diagnosis, providing digital solutions for rapid and secure cancer diagnosis. The company operates as a single unified product offering focused on connecting diagnostic laboratories and supporting clinical institutions facing challenges such as lack of pathologists and rising cancer cases.

Differentiator

Problem solved

Functional benefit

Products and services

  • DataPathology Platform

Quantifiable outcome

  • Increased network coverage for pathological diagnosis across Morocco and Africa

Companies that use DataPathology

Customer profile

Segments2 records

Ideal customer profiles2 records

DataPathology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

DataPathology partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

DataPathology competitors and assessment

Company assessment

Direct peers

  • PathAI: US-based AI pathology company providing digital diagnostic solutions for cancer. Directly comparable technology stack (digital pathology + AI-assisted diagnosis) and target end market (hospitals seeking accurate, scalable cancer diagnosis), though operating at much larger scale and capital base.
  • Proscia: Digital pathology platform company offering software for pathology workflows and AI-enabled cancer diagnosis. Closely comparable product category (cloud-based pathology platform serving hospitals and labs) with overlapping customer profile of clinical institutions seeking to modernize cancer diagnostics.
  • Ibex Medical Analytics: Israel-based AI pathology company focused on cancer diagnosis in clinical workflows. Direct overlap on AI-augmented cancer diagnosis for hospital labs; comparable technology positioning around augmenting pathologist capacity.
  • Paige.AI: Digital pathology AI company building clinical-grade diagnostic products for cancer. Directly comparable in the digital cancer diagnosis space with regulatory-cleared products serving similar hospital and reference lab customers.
  • Indica Labs: Provider of digital pathology image analysis software used by research and clinical pathology labs. Comparable as a pathology software platform serving laboratories, with overlapping customer base of diagnostic centers and hospitals.

Broad incumbents

  • Sectra: Swedish medical imaging IT company with a digital pathology module that integrates with hospital PACS systems. Comparable as a digital pathology vendor to hospitals, but operates as a broader imaging/IT incumbent rather than a pathology specialist.
  • Philips Digital Pathology: Multinational health technology major with a digital pathology solution sold to hospitals and labs. Comparable end market and use case (scanner + workflow + remote review), but part of a much broader medtech portfolio rather than a focused pathology offering.
  • Leica Biosystems (Danaher): Global pathology equipment and workflow vendor (owned by Danaher) covering slide scanners, reagents, and image management. Comparable customer base of pathology labs and hospitals, but competes via capital equipment and consumables rather than a software-first remote-diagnosis model.

Emerging players

  • Owkin: AI-for-health company with pathology and oncology applications for hospitals and pharma. Partial overlap on AI-driven cancer diagnosis; broader scope into drug discovery makes it an emerging adjacent player rather than a direct pathology services competitor.

Regional players

  • Hurone AI: US-based but Africa-focused oncology AI company building decision-support tools for cancer treatment in low-resource settings. Highly comparable mission (improving cancer care in underserved African contexts) and adjacent technology, making it the closest thematically aligned peer in DataPathology's geographic niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

DataPathology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DataPathology leadership team

Management profile

Number of profiles

Profiles2 records

DataPathology funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DataPathology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DataPathology

What does DataPathology do?

DataPathology provides a digital pathology platform that enables remote pathological diagnosis, offering rapid and secure digital solutions for cancer diagnosis. The platform serves hospitals, clinics, and diagnostic laboratories across Morocco and Africa, addressing the critical shortage of pathologists and rising cancer cases in underserved regions. The company operates a network of connected diagnostic centers to expand access to specialized pathology expertise.

Is DataPathology a public or private company?

DataPathology is a private company. It is classified as venture growth investor backed and is currently operating.

When was DataPathology founded?

DataPathology was founded in 2020. It employs 1 to 10 people.

Where is DataPathology based?

DataPathology is headquartered in Casablanca, Morocco, in the Africa region.

How does DataPathology make money?

One revenue line is on record: digital Pathology Diagnostic Services.

Who are DataPathology's main competitors?

Direct peers on record are PathAI, Proscia, Ibex Medical Analytics, Paige.AI and Indica Labs. Broad incumbents are Sectra, Philips Digital Pathology and Leica Biosystems (Danaher). Owkin is listed as an emerging player. Hurone AI is listed as a regional player.

Does DataPathology have an API?

No public API is recorded for DataPathology.

What industry is DataPathology in?

DataPathology's product category is Digital Pathology / Tele-pathology Diagnostics. Its primary akta.pro industry code is HLACAMAJ, Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces, with a secondary code of HLALAGAH, Oncology Telemedicine Platforms. Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Tech In AfricaTop 10 Digital Health Record Startups in AfricaTen African digital health record startups are profiled, including Helium Health, Click Doc, and DataPathology, with details on their platforms and impact. Helium Health reduced administrative tasks by 30% and improved patient throughput by 25% in Nigeria, while DataPathology cut diagnostic turnaround times by 40%.PR NewswireGestalt Expands Internationally with First Client in Africa: DataPathologyGestalt announced its first African client, DataPathology, onboarding its PathCloud platform to connect five laboratories in Morocco and Djibouti. The partnership aims to address a severe pathologist shortage, with Africa estimated at one pathologist per 500,000 people versus one per 15,000 in the U.S.AITNDataPathology a ouvert son capital à Azur Innovation FundMoroccan startup DataPathology has secured a 10 million dirham investment from Azur Innovation Fund to expand its remote pathological diagnostic services. This funding will support the company's growth within Morocco and across Africa, following previous investments and the development of its cervical cancer screening platform.Challenge.maDataPathology lève 10 millions de DH auprès d’Azur Innovation FundDataPathology, a Moroccan MedTech startup, has raised 10 million DH from Azur Innovation Fund to enhance its medical diagnostic solutions. This new funding follows an earlier 2 million DH investment from Witamax and aims to expand DataPathology's network of laboratories across Morocco and Africa amid rising cancer cases and a shortage of pathologists.Disrupt-africaMoroccan e-health startup DataPathology raises $223k funding – Old Disrupt AfricaMoroccan e-health startup DataPathology has raised MAD2 million (US$223,000) from investment company Witamax, founded by Southbridge A&I and Axxam Family Office, to expand its digital pathological diagnosis platform. Founded in 2020 by Hicham El Attar and Mohammed El Khannoussi, the company aims to address cancer diagnosis delays in rural areas. The funding will support deployment at new sites, team expansion and continental growth.Wamda.comMoroccan healthtech DataPathology raises $223,000Casablanca-based DataPathology raised $223,000 in a funding round led by WitamaxOne, backed by Southbridge A&I and AXXAM Family Office. The startup, founded in 2020, aims to improve remote pathological diagnosis for underserved countries. Funds will be deployed to transform diagnosis systems and enhance patient and practitioner services.Wamda.comMoroccan healthtech DataPathology raises $223,000Moroccan healthtech startup DataPathology raised $223,000 in a funding round led by WitamaxOne, with backing from Southbridge A&I and AXXAM Family Office. The company plans to use the capital to transform pathological diagnosis systems and improve services for patients and practitioners in medically underserved regions.TissuepathologyStartup DataPathology raises US$223,000Moroccan MedTech startup DataPathology has raised 2 MDH (US$223,000) from the investment company Witamax to expand its digital pathology services. The funding will be used to deploy new diagnostic sites and accelerate team recruitment across Morocco and Africa to address shortages in pathological diagnosis.Tech In AfricaMorocco medtech startup DataPathology raises $223K in funding roundMorocco-based medtech startup DataPathology has raised $223,000 in a funding round led by WitaMax One. The company plans to use the capital to transform pathological diagnosis systems and improve services for patients and practitioners in medically underserved regions. Founded in 2020, DataPathology aims to address delays in cancer diagnoses through digital biopsy solutions.